CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0097

Propionyl chloride CAS 79-03-8

Filed under Raw Materials. The bureau holds 123 laboratory returns for this compound from 39 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

39 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
HomopeptideCASE #VI-2026-0760 A 6 10.0 9.9 10.0 21 May 2026 21 May 2026
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 6 10.0 9.9 10.0 14 Nov 2025 16 Apr 2026
JEEP PeptidesCASE #VI-2026-0457 A 4 10.0 10.0 10.0 19 Dec 2025 8 Jul 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 4 10.0 9.9 10.0 28 Dec 2025 2 Jul 2026
Chinese Peptide CompanyCASE #VI-2026-0184 A 4 10.0 9.9 10.0 17 Apr 2026 15 Jul 2026
WuXi TIDESCASE #VI-2026-0335 A 4 10.0 10.0 10.0 25 Dec 2025 14 Jul 2026
Sigma-AldrichCASE #VI-2026-0829 A 4 10.0 9.9 10.0 3 Apr 2026 7 Aug 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 4 10.0 9.9 10.0 20 Apr 2026 18 Jul 2026
SinoPepCASE #VI-2026-0387 A 4 10.0 9.9 10.0 4 Mar 2026 26 Jun 2026
Hubei JianxiangCASE #VI-2026-0048 A 3 10.0 9.9 10.0 1 May 2026 13 Jul 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 3 10.0 9.9 10.0 14 Dec 2025 8 May 2026
BachemCASE #VI-2026-0314 A 2 10.0 10.0 10.0 8 Jan 2026 13 Jul 2026
Kerui PeptidesCASE #VI-2026-0626 A 2 10.0 10.0 10.0 14 Feb 2026 11 Mar 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 4 9.9 9.9 9.9 7 Jan 2026 25 Jun 2026
GenScript PeptidesCASE #VI-2026-0860 A 4 9.9 9.9 10.0 18 May 2026 19 Jul 2026
AmbioPharmCASE #VI-2026-0177 A 4 9.9 9.9 10.0 27 Jan 2026 7 Jun 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 3 9.9 9.9 10.0 16 Dec 2025 3 Jun 2026
AsymchemCASE #VI-2026-0091 A 3 9.9 9.9 10.0 4 Dec 2025 25 Jul 2026
Sangon BioCASE #VI-2026-0671 A 2 9.9 9.9 10.0 8 Dec 2025 20 Jun 2026
QYAOBIOCASE #VI-2026-0861 A 2 9.9 9.9 10.0 20 Jun 2026 28 Jun 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 2 9.9 9.9 10.0 13 Jan 2026 27 Mar 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 2 9.9 9.9 10.0 28 Feb 2026 17 Mar 2026
PolyPeptide GroupCASE #VI-2026-0143 A 2 9.9 9.9 10.0 14 May 2026 12 Aug 2026
Liberty PeptidesCASE #VI-2026-0416 X 1 9.8 9.8 9.8 9 Jun 2025 9 Jun 2025
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 5 9.1 8.3 10.0 23 May 2026 23 May 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 6 8.7 6.6 10.0 23 May 2026 23 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 3 8.6 8.0 9.3 21 May 2026 21 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704 A 5 8.4 6.7 9.9 21 May 2026 21 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 5 8.2 7.8 8.6 25 May 2026 25 May 2026
Mai PeptideCASE #VI-2026-0769 X 1 7.1 7.1 7.1 11 Jun 2025 11 Jun 2025
ZLZ PeptideCASE #VI-2026-0524 X 7 6.7 4.3 8.6 13 Feb 2025 23 May 2026
Xingtai Jiachuang TechnologyCASE #VI-2026-0712 X 1 6.3 6.3 6.3 17 Dec 2024 17 Dec 2024
Xingruida XDRCASE #VI-2026-0898 X 4 6.2 4.5 7.1 13 Jun 2025 19 Jan 2026
Hunan Ruiwang Technology CenterCASE #VI-2026-0027 X 1 5.9 5.9 5.9 28 Mar 2025 28 Mar 2025
Astro PeptidesCASE #VI-2026-0424 X 2 5.8 4.9 6.8 13 Jun 2025 20 May 2026
Peptide CraftersCASE #VI-2026-0994 X 1 5.8 5.8 5.8 13 Feb 2025 13 Feb 2025
Yabang PeptideCASE #VI-2026-0148 X 1 3.9 3.9 3.9 24 Apr 2025 24 Apr 2025
PepLab SolutionsCASE #VI-2026-0431 X 1 0.6 0.6 0.6 27 Feb 2025 27 Feb 2025
PRIVATECASE #VI-2026-0635 X 1 0.0 0.0 0.0 2 Jul 2025 2 Jul 2025

Open any subject to view the batch-level evidence for Propionyl chloride CAS 79-03-8 alone.